Big Pharma Watch: Study Finds Patent Thickets on Just Four Drugs Extended Monopolies By a Combined 25 Years

I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated $158 Billion for Big Pharma On Tuesday, the Initiative for Medicines, Access

09-20-2023 Read More

DOSE OF REALITY: BIG PHARMA’S TWO DECADES OF PRICE HIKES AND ADVERTISING BINGING ON TEN DRUGS ELIGIBLE FOR MEDICARE NEGOTIATION

A History of Big Pharma’s Egregious Pricing Practices and Billions of Dollars in Spending on Direct-to-Consumer Advertising The U.S. Department of Health and Human Services (HHS) announced the

09-20-2023 Read More

SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC

Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D — The Facts Disagree For far too long Big Pharma has used the excuse that research and development (R&D) costs justify

09-19-2023 Read More

CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL

Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer Investments Fueling Revenue for the Brand Name Drug Companies For Immediate Release Contact: Jon Conradi 860-235-3884

09-14-2023 Read More

CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients

Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity Medications More Than Five Times Higher Than Prices for Other Countries For Immediate Release Contact: Jon Conradi 860-235-3884

08-24-2023 Read More

BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET

AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226 Percent Each on Average Due to Big Pharma’s Price Hikes Last week, AARP’s Public Policy Institute released a new

08-17-2023 Read More

CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable

Americans from Across the Political Spectrum Want Congress to Pass Bipartisan Legislation to Crack Down on Big Pharma’s Abuse of the Patent System and Boost List Price Transparency For Immediate

08-16-2023 Read More

BIG PHARMA EARNINGS WATCH: SANOFI, ASTRAZENECA, AMGEN, ELI LILLY

Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of Second Quarter Earnings Reports While Continuing to Price-Gouge American Patients Rounding out Big Pharma’s earnings

08-14-2023 Read More

CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION

Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for “Secondary” Patents Compared to Original Patents for New Drugs For Immediate Release Contact: Jon Conradi 860-235-3884

08-9-2023 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.